MAP2K7 and melanoma: The addition of an anti- RAS, RAF, MEK, ERK agent, MEK inhibition (MEKi) has shown considerable effects and ability to inhibit growth and induce melanoma cell death, especially in the BRAF-mutant metastatic melanoma [192].